Skip to main content
Clinical Trials/KCT0007080
KCT0007080
Not Yet Recruiting
N/A

A Multicenter and prospective observational study to evaluate the effectiveness and safety of Rosuzet Tablet in patients with acute ischemic stroke

Chonnam National University Hospital0 sites1,500 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Diseases of the circulatory system
Sponsor
Chonnam National University Hospital
Enrollment
1500
Status
Not Yet Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) patients with acute ischemic stroke or transient ischemic attack with positive DWI lesions within 72 hours of onset and starting treatment with rosuzet within 3 days after admission; 2\) one of following a to d items, a) previous station or ezetimibe treatment, b) previous atherothrombotic diseases, needed to statin or lipid lowering agents, c) dyslipidemia, d) admission LDL\-C \>70 mg/dl; 3\) patients signed informed consent

Exclusion Criteria

  • 1\) contraindications of rosuzet, (1\) sensitivity to rosuzet (rosuvastatin or ezetimibe), (2\) active liver diseases, (3\) muscle diseases, (4\) cyclosporin treatment, (5\) severe chronic kidney disease; 2\) pregnant women or breastfeeding; 3\) ineligible for the study

Outcomes

Primary Outcomes

Not specified

Similar Trials